Author: ksandness
-
The Organization That Made History: How Medicines360’s New Innovation Hub Is Scaling Access-First Women’s Health Solutions
-
Medicines360 Appoints Erica Rogers to Board of Directors
-
Medicines360 and DKT WomanCare Announce Strategic Partnership to Expand Access to the Hormonal IUD Avibela™
-
Medicines360 Appoints Lisa David as Chair of the Board of Directors, Strengthening its Commitment to Women’s Health
-
Exploring Control in Contraceptive Use: Perspectives on IUD Self-Removal
-
FDA Approves Medicines360’s Supplemental New Drug Application for LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg as Treatment of Heavy Menstrual Bleeding